ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER

Clinical trials for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER trials appear

Sign up with your email to follow new studies for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Heart shield: statin may guard against chemo damage in breast cancer

Prevention Not yet recruiting

This study tests whether taking rosuvastatin, a cholesterol-lowering drug, can prevent heart damage caused by anthracycline chemotherapy in women with breast cancer. Four hundred participants will receive either rosuvastatin or a placebo daily for 12 months. The main goal is to s…

Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER

Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention

Last updated Jun 27, 2026 08:03 UTC

ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER

Get alerted when new ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER trials appear

Heart shield: statin may guard against chemo damage in breast cancer